BeautyHealth Surpasses 35,000 Hydrafacial Devices Worldwide Reflecting Growing Consumer Demand for Clinically Proven Skin Health Treatments
Underscores Hydrafacial's leadership and value to providers and consumers
Hydrafacial Syndeo Device
LONG BEACH, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ: SKIN), home to flagship brand Hydrafacial™, recently achieved a major milestone with 35,000 Hydrafacial devices installed worldwide, reinforcing its market leadership in the hydradermabrasion category it pioneered. This accomplishment highlights the Hydrafacial treatment's continued global demand, fueled by strong brand awareness, and growing consumer preferences for non-invasive, results-driven skin health treatments.
'With providers delivering approximately 5 million Hydrafacial treatments last year1, our position as one of the most in-demand professional skin health treatments is clear,' said BeautyHealth Chief Executive Officer, Marla Beck. 'For nearly 28 years, Hydrafacial has been a treatment room essential powered by our science-based innovation and portfolio of 175+ patents that deliver the glowing results that clients and providers love. With a global footprint of 35,000 active Hydrafacial devices worldwide, we're empowering our community to meet rising demand for non-invasive aesthetic treatments and inspire skin confidence around the world.'
Hydrafacial's success is backed by industry-leading consumer trust and satisfaction, ranking as the second most recognized facial treatment in the U.S.2 with a 96% 'Worth It' rating on RealSelf3, and an industry-leading 52 Net Promoter Score4. As a proven engine for practice growth, Hydrafacial treatments are responsible for driving approximately 7 percent of all new patients to medical spas and aesthetic practices each year.5 This enthusiasm for the brand translates to 1.5 Hydrafacial treatments performed every second around the world.6
The milestone reflects growing beauty trends favoring a natural, effortless look that prioritizes skin health – an aesthetic Hydrafacial treatments are uniquely designed to deliver. The Hydrafacial treatment combines seven powerful skin therapies in one: lymphatic drainage, a gentle peel, pain-free extractions, superficial microdermabrasion, a personalized booster, LED light therapy, and deep hydration. The result is visible skin improvements, a radiant glow, and a renewed boost in confidence – with zero downtime.
'We're grateful to the estheticians, dermatologists, and plastic surgeons who bring the iconic Hydrafacial glow to life every day,' Beck continues. 'Their trust and expertise drive our growth, and we remain committed to supporting them with ongoing innovation where MedTech Meets Beauty. Together, we're delivering real results – and a glow that keeps clients coming back.'
To experience the Hydrafacial treatment and discover why consumers and providers alike trust Hydrafacial for radiant, healthy skin, find a provider near you by visiting Hydrafacial.com/Find-a-Provider and follow along on social @Hydrafacial.
1Company Data. 2Ipsos Study 2024. Base: Consumers of the aesthetic and professional beauty category (n=1000); Brand Aided Awareness. Conversion defined as % of respondents who are aware of and have tried a given brand.3RealSelf as of April 2025. 4Consumers of the aesthetic and professional beauty category that have received a Hydrafacial (n=210); 'On a scale of 0 to 10, how likely are you to recommend Hydrafacial to a friend or colleague?'5Guidepoint Qsight - Sales Measurement as of March 2025.6Treatments per second calculation based on 5 million treatments/year, spread across a 40-hour work week, 50 weeks in a year.
About The Beauty Health CompanyThe Beauty Health Company (NASDAQ: SKIN) is a medtech meets beauty company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in microneedling, and Keravive™ in scalp health. Together, with our powerful global community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider/ and learn more at beautyhealth.com or LinkedIn.
Forward-Looking StatementsCertain statements made in this release are 'forward looking statements' within the meaning of the 'safe harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words 'estimates,' 'projected,' 'expects,' 'anticipates,' 'forecasts,' 'plans,' 'intends,' 'believes,' 'seeks,' 'may,' 'will,' 'should,' 'future,' 'propose' and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements
These forward-looking statements are not guarantees of future performance, conditions, or results, and involve a number of known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside The Beauty Health Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.
Important factors, among others, that may affect actual results or outcomes include The Beauty Health Company's ability to execute its business plan; consumers' perception of skin health, skin concerns, and overall beauty trends; the continued relationship amongst Hydrafacial, its providers, and consumers; the ability to place and continue to place delivery systems across various channels and locations; potential litigation involving The Beauty Health Company; changes in applicable laws or regulations; and the possibility that The Beauty Health Company may be adversely affected by other economic, business, and/or competitive factors. The Beauty Health Company does not undertake any obligation to update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by law.Contacts:Hydrafacial Media Contact: Devries Global: jburchette@devriesglobal.com Investors: IR@beautyhealth.com
Source: BeautyHealth
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/82957630-5f2e-456e-bf28-02946fb3ba08
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Dr. Louis Krenn Medical Scholarship Invites Aspiring Physicians to Shape the Future of Healthcare
Dr. Louis Krenn SPRINGFIELD, Mo., June 06, 2025 (GLOBE NEWSWIRE) -- The Dr. Louis Krenn Medical Scholarship announces a new opportunity for undergraduate and medical students across the United States to advance their journey toward a career in medicine. This prestigious one-time award, established by Dr. Louis Krenn, a distinguished Family Medicine physician, aims to support the next generation of healthcare professionals who demonstrate a commitment to service, innovation, and compassion. The scholarship, open to students nationwide, invites applicants to share their vision for the future of medicine through a thought-provoking essay. The Dr. Louis Krenn Medical Scholarship seeks to recognize students who view medicine as more than a profession but as a calling to make a meaningful impact. Eligible applicants must be current undergraduate or medical students in the United States actively pursuing a career in medicine, either on a pre-med or medical school track. To apply, candidates are required to submit an original essay of 500–800 words responding to the prompt: 'Medicine is more than a career—it's a calling. What inspired you to pursue a path in healthcare, and how do you hope to shape the future of medicine through your work?' Essays will be evaluated based on originality, depth of reflection, and alignment with the values of service, innovation, and compassion that define Dr. Louis Krenn's legacy. Dr. Louis Krenn, a seasoned physician with over two decades of experience, established this scholarship to inspire and support students who share his dedication to advancing healthcare. Dr. Louis Krenn has held various leadership roles, including Medical Director of Ambulatory Clinical Efficiency, Chief Medical Information Officer, and Director of Telehealth. His work has focused on improving clinical workflows and expanding telehealth access, reflecting his commitment to innovation in patient care. Beyond his clinical and leadership roles, Dr. Louis Krenn is a passionate educator, having mentored countless medical, nursing, and physician assistant students. The scholarship reflects his mission to foster the growth of future physicians who will lead with compassion and drive progress in the medical field. The application process is straightforward, encouraging students to articulate their motivations and aspirations in healthcare. The deadline for submissions is March 15, 2026, with the winner announced on April 15, 2026. The selected recipient will receive a one-time award to support their educational journey. Detailed application instructions and eligibility criteria are available at The Dr. Louis Krenn Medical Scholarship stands as a testament to the importance of nurturing talent in healthcare. By offering this opportunity, the scholarship aims to encourage students to pursue their dreams in medicine while contributing to a brighter, more compassionate future for the industry. Interested applicants are encouraged to visit the official website to learn more and submit their essays. This initiative not only honors Dr. Louis Krenn's contributions to medicine but also invests in the potential of students who will shape the healthcare landscape for years to come. About the Dr. Louis Krenn Medical Scholarship The Dr. Louis Krenn Medical Scholarship is dedicated to supporting undergraduate and medical students pursuing careers in medicine. Founded by Dr. Louis Krenn, the scholarship promotes the values of service, innovation, and compassion in healthcare, aiming to inspire the next generation of physicians to make a lasting impact. For more information, please contact: Spokesperson: Dr. Louis Krenn Organization: Dr. Louis Krenn Scholarship Website: Email: apply@ A photo accompanying this announcement is available at in to access your portfolio
Yahoo
an hour ago
- Yahoo
American Botanical Council Acquires Full Rights to Steven Foster Photo Library
The nonprofit now owns more than 150,000 images of 1,700+ species of medicinal and aromatic plants taken by famed photographer and herbal expert Echinacea Purpurea Passiflora Incarnata Austin, Texas, June 06, 2025 (GLOBE NEWSWIRE) -- The nonprofit American Botanical Council (ABC) announces that it has obtained ownership rights to the entire collection of medicinal and aromatic plant photographs taken by the late botanist, author, and preeminent photographer Steven Foster (1957–2022).Foster was well-known and widely respected as the author or co-author of 21 books on herbs and medicinal plants. He also wrote more than 800 articles and reviews on herbal medicine, ethnobotany, sustainable sourcing, conservation, and related subjects, including more than 100 articles and reviews in ABC's peer-reviewed journal HerbalGram. His extensive photographic library includes more than 150,000 images of more than 1,700 accurately identified medicinal and aromatic plant species. This includes Foster's photos of many native American medicinal plants, as well as other plants he encountered during his travels in countries around the world, including Argentina, Armenia, Belize, China, Costa Rica, Egypt, England, Georgia, Germany, Guatemala, Japan, Montenegro, the Netherlands, Peru, Switzerland, Trinidad and Tobago, Vietnam, and elsewhere. Foster was a member of ABC's Board of Trustees for more than 20 years and president for 10 years. He provided frequent and instrumental support for HerbalGram and served as a contributing editor, peer reviewer, and author of dozens of feature-length articles. He also contributed hundreds of medicinal plant photos from his extensive library, including at least 60 photos that appeared on the magazine's cover. His photography filled nearly every issue of HerbalGram since issue 24 in 1991. After Foster's untimely death in January 2022, ABC continued to have access to and permission to use his photos in a variety of ABC publications and communications through a special arrangement with his estate. ABC continued to feature his photos on ABC's website, in publications of the ABC-AHP-NCNPR Botanical Adulterants Prevention Program (BAPP), and in HerbalGram, ABC's monthly newsletter HerbalEGram, ABC's weekly newsletter Herbal News & Events, and other ABC publications. Now, ABC has finalized the purchase of Foster's entire digital photo library, including full rights to all of the images. Credits to Foster's photographs will now read: 'Photo by Steven Foster ©2025 ABC.' 'For more than 40 years, Steven was a close personal friend and colleague and a primary contributor to ABC's nonprofit research and educational mission, publications, and programs,' said ABC Founder and Executive Director Mark Blumenthal. 'Steven's intelligence, botanical knowledge, insightful and deeply informed writing, and his compelling photography were an integral part of the development and evolution of HerbalGram and ABC. 'It has been ABC's goal not only to provide authoritative, reliable, science-based information on herbs and medicinal plants, but also to show the beauty of these plants, which we have done for decades thanks in large part to Steven's incredibly beautiful photos,' Blumenthal added. 'Now, ABC has the opportunity to continue its nonprofit educational mission with Steven's photos and to help expand the herb community and general public's awareness of and appreciation for Steven's remarkable photographic legacy. ABC Art Director Matt Magruder said: 'Securing the ownership of Steven Foster's photography library is an exciting new chapter for HerbalGram and all of ABC's various programs and publications. Steven's photography has been a foundational — and visually stunning — part of the organization from early on. As a fellow photographer, I am grateful to be able to honor Steven and to continue to share his quintessential photographic legacy through ABC's stewardship moving forward.' Michael J. Balick, PhD, member of ABC's Board of Trustees and vice president for botanical science, director and senior philecology curator of the Institute of Economic Botany at the New York Botanical Garden, said: 'I was delighted to learn that ABC has acquired the Steven Foster Photo Library. Steven's 'plant's eye view' was nothing short of extraordinary, and this is reflected in all of the artistic and scientific work that he did over so many decades. He was enthusiastic and generous about sharing his talents as a photographer and providing his guidance to anyone who asked for his advice, regardless of their level of botanical sophistication. When I invited him to illustrate the third edition of the Handbook of Poisonous and Injurious Plants [Springer, 2017], he provided his best work, and the photos that grace the pages of this reference book are not only useful for identification in cases of suspected poisoning, but also works of beautifully composed botanical art. We all miss Steven, who left us prematurely, and I am grateful to ABC and its donors for ensuring that this part of his legacy will endure, educating and captivating us all for many more decades.' Blumenthal noted that, at a time when people are beginning to use artificial intelligence as a source for botanical images, one primary benefit of Foster's photographs is the reliable and accurate identification of the depicted plant species. As an expert botanist, Foster properly identified the botanicals in his photos. Aside from the beauty of the photos, this benefit is a key feature of ABC's Steven Foster Photo Library. ABC featured a memorial tribute to Steven Foster in HerbalGram issue 133 and a pictorial of some of his medicinal plant photography in issue 134. A new pictorial of Foster's brilliant medicinal plant photos was just published in the current issue of HerbalGram, issue 143. In addition, ABC has named its newest award for botanical excellence after Foster, the ABC Steven Foster Excellence in Botanical Conservation and Sustainability Award, which is announced each spring at the annual ABC Celebration at Natural Products Expo West in Anaheim. Attachments Echinacea Purpurea Passiflora Incarnata CONTACT: Public Relations American Botanical Council 512-926-4900 ext. 129 publicrelations@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Abacus Global Management Announces Share Repurchase Program; Insider Buying
ORLANDO, Fla., June 06, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. ('Abacus' or the 'Company') (NASDAQ: ABL), a leader in the alternative asset management space, today announced that its Board of Directors has authorized a new $20 million share repurchase program, effective June 5, 2025 for over a period of up to 18 months, as well as recent Form 4 and other employee share purchases totaling over $2 million. "While it is unfortunate that Abacus Global Management has been subject to a short attack, we believe our artificially depressed share price represents an excellent buying opportunity for the Company,' said Jay Jackson, Chief Executive Officer of Abacus Global Management. 'We believe this is validated by our newly authorized share repurchase program, reflecting our Board's continued confidence in our business model and strength of our balance sheet, and also by our employees who have spent over $2 million combined of their own money in recent share purchases. Our returns and valuation are audited, and consistent with a 20-year track record of generating positive revenue. We will not allow this distraction to affect our continued growth and our day-to-day operations.' During the pendency of the stock repurchase program, the Company may repurchase shares from time to time through various methods, including in open market transactions, block trades, accelerated share repurchases, privately negotiated transactions, derivative transactions or otherwise, certain of which may be made pursuant to a trading plan meeting the requirements of Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, in compliance with applicable state and federal securities laws. The timing, as well as the number and value of shares repurchased under the program, will be determined by the Company at its discretion and will depend on a variety of factors, including our assessment of the intrinsic value of the Company's common stock, the market price of the Company's common stock, general market and economic conditions, available liquidity, compliance with the Company's debt and other agreements, applicable legal requirements, the nature of other investment opportunities available to the Company, and other considerations. The Company is not obligated to purchase any shares under the repurchase program, and the program may be suspended, modified, or discontinued at any time without prior notice. The Company expects to fund the repurchases by using cash on hand and expected free cash flow to be generated in the future. Abacus is committed to pursuing all available legal remedies against the individuals and entities responsible for orchestrating and disseminating the false and misleading short attack. Forward-Looking Statements All statements in this press release (and oral statements made regarding the subjects of this press release) other than historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of uncertainties and factors that could cause actual results to differ materially from such statements, many of which are outside the control of Abacus. Forward-looking information includes but is not limited to statements regarding: Abacus's financial and operational outlook; Abacus's operational and financial strategies, including planned growth initiatives and the benefits thereof, Abacus's ability to successfully effect those strategies, and the expected results therefrom. These forward-looking statements generally are identified by the words 'believe,' 'project,' 'estimate,' 'expect,' 'intend,' 'anticipate,' 'goals,' 'prospects,' 'will,' 'would,' 'will continue,' 'will likely result,' and similar expressions (including the negative versions of such words or expressions). While Abacus believes that the assumptions concerning future events are reasonable, it cautions that there are inherent difficulties in predicting certain important factors that could impact the future performance or results of its business. The factors that could cause results to differ materially from those indicated by such forward-looking statements include, but are not limited to: the fact that Abacus's loss reserves are bases on estimates and may be inadequate to cover its actual losses; the failure to properly price Abacus's insurance policies; the geographic concentration of Abacus's business; the cyclical nature of Abacus's industry; the impact of regulation on Abacus's business; the effects of competition on Abacus's business; the failure of Abacus's relationships with independent agencies; the failure to meet Abacus's investment objectives; the inability to raise capital on favorable terms or at all; the effects of acts of terrorism; and the effectiveness of Abacus's control environment, including the identification of control deficiencies. These forward-looking statements are also affected by the risk factors, forward-looking statements and challenges and uncertainties set forth in documents filed by Abacus with the U.S. Securities and Exchange Commission from time to time, including the Annual Report on Form 10-K and Quarterly Reports on Form 10-Q and subsequent periodic reports. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Abacus cautions you not to place undue reliance on the forward-looking statements contained in this press release. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and Abacus assumes no obligation and, except as required by law, does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Abacus does not give any assurance that it will achieve its expectations. About Abacus Abacus Global Management (NASDAQ: ABL) is a leading financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. With a focus on longevity-based assets and personalized financial planning, Abacus leverages proprietary data analytics and decades of industry expertise to deliver innovative solutions that optimize financial outcomes for individuals and institutions worldwide. Contacts: Investor Relations Robert F. Phillips – SVP Investor Relations and Corporate Affairsrob@ 290-1198 David Jackson – Director of IR/Capital Marketsdavid@ 299-0716 Abacus Global Management Public Relations press@
